本页面由Tiger Trade Technology Pte. Ltd.提供服务

Phathom Pharmaceuticals

12.02
-0.2100-1.72%
盘前12.170.1500+1.25%09:03 EST
成交量:64.81万
成交额:779.33万
市值:9.41亿
市盈率:-3.16
高:12.41
开:12.38
低:11.83
收:12.23
52周最高:18.31
52周最低:2.21
股本:7,829.48万
流通股本:5,756.69万
量比:0.79
换手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-3.8010
每股收益(LYR):-5.2920
净资产收益率:-3489.00%
总资产收益率:-42.54%
市净率:-2.23
市盈率(LYR):-2.27

数据加载中...

公司资料

公司名字:
Phathom Pharmaceuticals
交易所:
NASDAQ
成立时间:
2018
员工人数:
427
公司地址:
100 Campus Drive,Suite 102,Florham Park,New Jersey,United States
邮编:
07932
电话:
传真:
- -
简介:
Phathom Pharmaceuticals, Inc.于2018年1月9日根据特拉华州法律注册成立。该公司是一家生物制药公司,专注于开发和商业化治疗胃肠道疾病或GI疾病的新疗法。

董事

名称
职位
Michael F. Cola
Director and Chairman
Steven Basta
President, Chief Executive Officer and Director
Asit Parikh
Director
Frank Karbe
Director
Heidi Kunz
Director
James Topper
Director
Mark Stenhouse
Director
Theodore R. Schroeder
Director

股东

名称
职位
Steven Basta
President, Chief Executive Officer and Director
Azmi Nabulsi
Chief Operating Officer
Molly Henderson
Chief Financial and Business Officer
Robert Breedlove
Principal Accounting Officer
Sanjeev Narula
Chief Financial and Business Officer and Principal Financial Officer